Relonchem receives UK MHRA approval for Moxonidine 200mg/400 mg tablets

Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:

1. Moxonidine 200 microgram Tablets
2. Moxonidine 400 microgram Tablets

Powered by Capital Market - Live News